Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,757,912
  • Shares Outstanding, K 81,885
  • Annual Sales, $ 3,661 M
  • Annual Income, $ 845,040 K
  • EBIT $ 1,112 M
  • EBITDA $ 1,227 M
  • 60-Month Beta 1.37
  • Price/Sales 9.22
  • Price/Cash Flow 35.67
  • Price/Book 20.86

Options Overview Details

View History
  • Implied Volatility 29.17% ( -0.05%)
  • Historical Volatility 24.58%
  • IV Percentile 58%
  • IV Rank 29.88%
  • IV High 46.25% on 08/05/24
  • IV Low 21.89% on 05/17/24
  • Put/Call Vol Ratio 0.07
  • Today's Volume 47
  • Volume Avg (30-Day) 335
  • Put/Call OI Ratio 1.76
  • Today's Open Interest 5,218
  • Open Int (30-Day) 10,263

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 2.40
  • Number of Estimates 7
  • High Estimate 2.47
  • Low Estimate 2.34
  • Prior Year 2.32
  • Growth Rate Est. (year over year) +3.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
404.36 +1.62%
on 12/20/24
453.26 -9.34%
on 12/09/24
-6.33 (-1.52%)
since 11/22/24
3-Month
398.50 +3.11%
on 11/21/24
518.97 -20.82%
on 09/27/24
-96.75 (-19.06%)
since 09/23/24
52-Week
398.50 +3.11%
on 11/21/24
583.39 -29.57%
on 03/01/24
-143.13 (-25.83%)
since 12/22/23

Most Recent Stories

More News
A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025

One of my favorite ways to add money to my portfolio is to invest in proven compounders with track records of delivering market-beating results after short-term pullbacks. This idea is especially true...

ZTS : 163.58 (-0.76%)
IDXX : 410.49 (-0.43%)
Is IDEXX Laboratories Stock Underperforming the S&P 500?

IDEXX Laboratories has continued to underperform the S&P 500 over the past year, yet analysts remain moderately bullish on the stock’s prospects.

$SPX : 5,921.20 (-0.16%)
IDXX : 410.49 (-0.43%)
NEOG : 11.98 (-0.50%)
Insider Sale: Director at $IDXX (IDXX) Sells 344 Shares

Sophie V. Vandebroek, a director at $IDXX ($IDXX), sold 344 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 27.5% of their...

IDXX : 410.49 (-0.43%)
IDEXX Laboratories Stock Outlook: Is Wall Street Bullish or Bearish?

Despite IDEXX Laboratories’ underperformance relative to the broader market over the past year, Wall Street analysts remain moderately bullish about the stock’s prospects.

XLV : 137.55 (-0.33%)
$SPX : 5,921.20 (-0.16%)
IDXX : 410.49 (-0.43%)
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?

Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today.

SMCI : 32.15 (+1.77%)
IDXX : 410.49 (-0.43%)
REGN : 713.61 (+1.68%)
MRNA : 40.30 (+2.31%)
DELL : 118.17 (+2.07%)
ASML : 712.03 (+0.90%)
A Once-in-a-Decade Opportunity: 1 Super S&P 500 Stock Down 40% to Buy After Its Recent Pullback

Trading at its most reasonable valuation since 2016, this pet healthcare diagnostics leader could be a once-in-a-decade opportunity today.

IDXX : 410.49 (-0.43%)
Idexx: Q3 Earnings Snapshot

Idexx: Q3 Earnings Snapshot

IDXX : 410.49 (-0.43%)
IDEXX Laboratories' Q3 2024 Earnings: What to Expect

IDEXX Laboratories is scheduled to release its fiscal third-quarter earnings this month, and analysts project a single-digit profit growth.

XLV : 137.55 (-0.33%)
$SPX : 5,921.20 (-0.16%)
IDXX : 410.49 (-0.43%)
Are Options Traders Betting on a Big Move in IDEXX Laboratories (IDXX) Stock?

Investors in IDEXX Laboratories, Inc.IDXX need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 20, 2024 $210.00 Call had some of the highest implied...

IDXX : 410.49 (-0.43%)
How Is IDEXX Laboratories' Stock Performance Compared to Other Healthcare Stocks?

IDEXX Laboratories underperformed the broader healthcare sector, but Wall Street analysts remain moderately optimistic about the stock’s prospects.

IDXX : 410.49 (-0.43%)
IHI : 58.31 (-0.85%)
TMO : 523.73 (-0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

IDEXX Laboratories, Inc. is a developer, manufacturer and distributer of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care...

See More

Key Turning Points

3rd Resistance Point 432.79
2nd Resistance Point 425.53
1st Resistance Point 418.89
Last Price 410.49
1st Support Level 404.99
2nd Support Level 397.73
3rd Support Level 391.09

See More

52-Week High 583.39
Fibonacci 61.8% 512.76
Fibonacci 50% 490.95
Fibonacci 38.2% 469.13
Last Price 410.49
52-Week Low 398.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar